Your browser doesn't support javascript.
loading
Systemic Intravenous Adoptive Transfer of Autologous Lymphokine-activated αß T-Cells Improves Temozolomide-induced Lymphopenia in Patients with Glioma.
Kanemura, Yonehiro; Sumida, Miho; Okita, Yoshiko; Yoshioka, Ema; Yamamoto, Atsuyo; Kanematsu, Daisuke; Handa, Yukako; Fukusumi, Hayato; Inazawa, Yui; Takada, A I; Nonaka, Masahiro; Nakajima, Shin; Mori, Kanji; Goto, Shigenori; Kamigaki, Takashi; Shofuda, Tomoko; Moriuchi, Shusuke; Yamasaki, Mami.
Afiliación
  • Kanemura Y; Division of Regenerative Medicine, Institute for Clinical Research, Osaka National Hospital, National Hospital Organization, Osaka, Japan kanemura@onh.go.jp.
  • Sumida M; Department of Neurosurgery, Osaka National Hospital, National Hospital Organization, Osaka, Japan.
  • Okita Y; Division of Regenerative Medicine, Institute for Clinical Research, Osaka National Hospital, National Hospital Organization, Osaka, Japan.
  • Yoshioka E; Department of Neurosurgery, Osaka National Hospital, National Hospital Organization, Osaka, Japan.
  • Yamamoto A; Division of Stem Cell Research, Institute for Clinical Research, Osaka National Hospital, National Hospital Organization, Osaka, Japan.
  • Kanematsu D; Division of Stem Cell Research, Institute for Clinical Research, Osaka National Hospital, National Hospital Organization, Osaka, Japan.
  • Handa Y; Division of Regenerative Medicine, Institute for Clinical Research, Osaka National Hospital, National Hospital Organization, Osaka, Japan.
  • Fukusumi H; Division of Regenerative Medicine, Institute for Clinical Research, Osaka National Hospital, National Hospital Organization, Osaka, Japan.
  • Inazawa Y; Division of Stem Cell Research, Institute for Clinical Research, Osaka National Hospital, National Hospital Organization, Osaka, Japan.
  • Takada AI; Division of Regenerative Medicine, Institute for Clinical Research, Osaka National Hospital, National Hospital Organization, Osaka, Japan.
  • Nonaka M; Division of Regenerative Medicine, Institute for Clinical Research, Osaka National Hospital, National Hospital Organization, Osaka, Japan.
  • Nakajima S; Department of Neurosurgery, Osaka National Hospital, National Hospital Organization, Osaka, Japan.
  • Mori K; Department of Neurosurgery, Kansai Medical University, Hirakata, Japan.
  • Goto S; Department of Neurosurgery, Osaka National Hospital, National Hospital Organization, Osaka, Japan.
  • Kamigaki T; Department of Neurosurgery, Hyogo College of Medicine, Nishinomiya, Japan.
  • Shofuda T; Department of Neurosurgery, Kansai Rosai Hospital, Amagasaki, Japan.
  • Moriuchi S; Seta Clinic Group, Tokyo, Japan.
  • Yamasaki M; Seta Clinic Group, Tokyo, Japan.
Anticancer Res ; 37(7): 3921-3932, 2017 07.
Article en En | MEDLINE | ID: mdl-28668896
Asunto(s)
Palabras clave
Buscar en Google
Imprimir
XML
PubMed Links

Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Subgrupos de Linfocitos T / Dacarbazina / Glioma / Linfopenia Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Anticancer Res Año: 2017 Tipo del documento: Article País de afiliación: Japón
Buscar en Google
Imprimir
XML
PubMed Links

Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Subgrupos de Linfocitos T / Dacarbazina / Glioma / Linfopenia Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Anticancer Res Año: 2017 Tipo del documento: Article País de afiliación: Japón